MKS (MKSI) Financials

$294.04 -1.66 (-0.56%)

Closing price 04:00 PM Eastern

Extended Trading

$293.92 -0.12 (-0.04%)

As of 07:23 PM Eastern

Annual Income Statements for MKS

This table shows MKS's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	122	105	339	393	140	350	551	333	-1,841	190	295
Consolidated Net Income / (Loss)	122	105	339	393	140	350	551	333	-1,841	190	295
Net Income / (Loss) Continuing Operations	122	105	339	393	140	350	551	333	-1,841	190	295
Total Pre-Tax Income	159	128	448	481	178	423	665	433	-1,928	180	304
Total Operating Income	157	157	407	494	220	454	699	617	-1,554	498	528
Total Gross Profit	363	1,295	891	980	830	1,049	1,380	1,547	1,642	1,708	1,837
Total Revenue	814	1,295	1,916	2,075	1,900	2,330	2,950	3,547	3,622	3,586	3,931
Operating Revenue	814	1,295	1,916	2,075	1,900	2,330	2,950	3,547	3,622	3,586	3,931
Total Cost of Revenue	451	0.00	1,025	1,096	1,069	1,281	1,570	2,000	1,980	1,878	2,094
Operating Cost of Revenue	451	-	1,025	1,096	1,069	1,281	1,570	2,000	1,980	1,878	2,094
Total Operating Expenses	206	1,138	485	485	611	595	681	930	3,196	1,210	1,309
Selling, General & Admin Expense	129	228	290	298	330	353	385	488	675	674	724
Research & Development Expense	68	111	133	136	164	173	200	241	288	271	299
Amortization Expense	6.76	36	46	44	67	55	55	146	295	245	247
Other Operating Expenses / (Income)	-	731	0.49	0.40	6.60	-	0.00	0.00	2.00	5.00	2.00
Impairment Charge	-	5.00	6.72	0.00	4.70	-	0.00	0.00	1,902	0.00	0.00
Restructuring Charge	2.10	28	9.25	7.70	44	14	41	62	36	15	37
Other Special Charges / (Income)	-	-	-	0.00	-6.80	0.00	0.00	-7.00	-2.00	0.00	0.00
Total Other Income / (Expense), net	2.86	-29	41	-13	-42	-31	-34	-184	-374	-318	-224
Interest Expense	0.14	31	31	17	44	29	25	177	364	341	222
Interest & Investment Income	3.00	2.56	3.02	5.80	5.40	1.00	0.00	4.00	17	21	14
Other Income / (Expense), net	-	-1.24	69	-2.00	-3.30	-3.00	-9.00	-11	-27	2.00	-16
Income Tax Expense	37	23	108	88	37	73	114	100	-87	-10	9.00
Basic Earnings per Share	$2.30	$1.96	$6.26	$7.22	$2.57	$6.36	$9.95	$5.57	($27.54)	$2.82	$4.39
Weighted Average Basic Shares Outstanding	53.28M	53.47M	54.14M	54.41M	54.70M	55.10M	55.40M	59.70M	66.80M	67.30M	67.30M
Diluted Earnings per Share	$2.28	$1.94	$6.16	$7.14	$2.55	$6.33	$9.90	$5.56	($27.54)	$2.81	$4.37
Weighted Average Diluted Shares Outstanding	53.56M	54.05M	55.07M	55M	55.10M	55.30M	55.70M	59.90M	66.80M	67.60M	67.70M
Weighted Average Basic & Diluted Shares Outstanding	53.20M	53.50M	54.20M	54.40M	54.87M	55.22M	55.52M	66.67M	67.06M	67.38M	67.25M
Cash Dividends to Common per Share	$0.68	$0.68	$0.71	$0.78	$0.80	$0.80	$0.86	$0.88	$0.88	$0.88	$0.88

This table shows MKS's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	39	-69	15	23	62	90	52	62	74	107	84
Consolidated Net Income / (Loss)	39	-69	15	23	62	90	52	62	74	107	84
Net Income / (Loss) Continuing Operations	39	-69	15	23	62	90	52	62	74	107	84
Total Pre-Tax Income	22	-80	19	22	60	79	59	72	84	89	102
Total Operating Income	118	23	106	127	128	137	111	135	138	144	149
Total Gross Profit	426	411	415	419	432	442	444	453	461	479	507
Total Revenue	932	893	868	887	896	935	936	973	988	1,034	1,078
Operating Revenue	932	893	868	887	896	935	936	973	988	1,034	1,078
Total Cost of Revenue	506	482	453	468	464	493	492	520	527	555	571
Operating Cost of Revenue	506	482	453	468	464	493	492	520	527	555	571
Total Operating Expenses	308	388	309	292	304	305	333	318	323	335	358
Selling, General & Admin Expense	167	162	170	161	167	176	185	175	180	184	190
Research & Development Expense	71	70	70	66	70	65	70	76	76	77	81
Amortization Expense	68	70	62	61	61	61	60	62	63	62	63
Other Operating Expenses / (Income)	0.00	2.00	3.00	0.00	2.00	-	2.00	0.00	0.00	-	18
Restructuring Charge	4.00	9.00	4.00	4.00	4.00	3.00	16	5.00	4.00	12	3.00
Other Special Charges / (Income)	-2.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	3.00
Total Other Income / (Expense), net	-96	-103	-87	-105	-68	-58	-52	-63	-54	-55	-47
Interest Expense	93	98	96	117	69	59	56	57	55	54	50
Interest & Investment Income	4.00	6.00	6.00	5.00	6.00	4.00	3.00	4.00	3.00	4.00	2.00
Other Income / (Expense), net	-7.00	-11	3.00	7.00	-5.00	-3.00	1.00	-10	-2.00	-5.00	1.00
Income Tax Expense	-17	-11	4.00	-1.00	-2.00	-11	7.00	10	10	-18	18
Basic Earnings per Share	$0.59	($1.02)	$0.22	$0.34	$0.92	$1.34	$0.77	$0.92	$1.10	$1.60	$1.24
Weighted Average Basic Shares Outstanding	66.90M	66.80M	67M	67.30M	67.40M	67.30M	67.40M	67.20M	67.30M	67.30M	67.40M
Diluted Earnings per Share	$0.58	($1.01)	$0.22	$0.33	$0.92	$1.34	$0.77	$0.92	$1.10	$1.58	$1.18
Weighted Average Diluted Shares Outstanding	67.10M	66.80M	67.40M	67.50M	67.60M	67.60M	67.70M	67.40M	67.60M	67.70M	71.10M
Weighted Average Basic & Diluted Shares Outstanding	66.88M	67.06M	67.20M	67.29M	67.30M	67.38M	67.07M	67.16M	67.17M	67.25M	67.54M
Cash Dividends to Common per Share	$0.22	-	$0.22	$0.22	$0.22	-	$0.22	$0.22	$0.22	-	$0.25

This table details how cash moves in and out of MKS's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-78	6.34	100	309	-230	193	358	-57	-34	-161	-39
Net Cash From Operating Activities	138	180	355	414	245	513	640	529	319	528	645
Net Cash From Continuing Operating Activities	138	180	355	414	245	513	640	529	319	528	645
Net Income / (Loss) Continuing Operations	122	105	339	393	140	350	551	333	-1,841	190	295
Consolidated Net Income / (Loss)	122	105	339	393	140	350	551	333	-1,841	190	295
Depreciation Expense	22	66	83	80	110	99	104	216	397	348	344
Amortization Expense	-	24	11	4.70	15	3.00	2.00	108	33	30	26
Non-Cash Adjustments To Reconcile Net Income	26	46	11	54	72	58	57	62	2,031	169	110
Changes in Operating Assets and Liabilities, net	-32	-61	-88	-117	-93	3.00	-74	-190	-301	-209	-130
Net Cash From Investing Activities	-167	-727	23	73	-947	-202	-205	-4,552	-84	-117	-145
Net Cash From Continuing Investing Activities	-167	-727	23	73	-947	-202	-205	-4,552	-84	-117	-145
Purchase of Property, Plant & Equipment	-12	-19	-31	-63	-64	-85	-87	-164	-87	-118	-148
Acquisitions	-9.91	-940	-	0.00	-989	0.00	-268	-4,473	0.00	0.00	0.00
Purchase of Investments	-386	-268	-230	-254	-246	-522	-497	-1.00	0.00	0.00	0.00
Sale of Property, Plant & Equipment	-	-	-	0.00	42	0.00	0.00	9.00	3.00	1.00	3.00
Sale and/or Maturity of Investments	241	500	211	389	310	405	647	77	0.00	0.00	0.00
Net Cash From Financing Activities	-47	560	-280	-178	476	-122	-65	3,971	-259	-549	-562
Net Cash From Continuing Financing Activities	-47	560	-280	-178	476	-122	-65	3,971	-259	-549	-562
Repayment of Debt	-	-165	-258	-117	-112	-84	-15	-1,213	-415	-2,642	-454
Repurchase of Common Equity	-13	-1.55	-	-75	-	-	-	-	0.00	0.00	-45
Payment of Dividends	-36	-36	-38	-42	-44	-44	-47	-52	-59	-59	-59
Issuance of Debt	-	764	29	68	642	27	1.00	5,237	216	2,161	0.00
Other Financing Activities, net	2.17	-0.45	-12	-11	-11	-21	-4.00	-1.00	-1.00	-9.00	-4.00
Other Net Changes in Cash	-	-6.90	1.81	-	-3.20	-	-	-	-	-	23
Cash Interest Paid	0.03	21	20	15	40	26	23	110	305	268	190
Cash Income Taxes Paid	43	45	105	92	36	66	110	133	0.00	0.00	0.00

This table details how cash moves in and out of MKS's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	102	16	-30	5.00	11	-147	-59	19	23	-22	-106
Net Cash From Operating Activities	160	181	67	122	163	176	141	165	197	142	53
Net Cash From Continuing Operating Activities	160	181	67	122	163	176	141	165	197	142	53
Net Income / (Loss) Continuing Operations	40	-69	15	22	62	91	52	62	74	107	84
Consolidated Net Income / (Loss)	40	-69	15	22	62	91	52	62	74	107	84
Depreciation Expense	93	96	88	87	87	86	85	87	86	86	85
Amortization Expense	8.00	10	8.00	8.00	7.00	7.00	6.00	7.00	7.00	6.00	4.00
Non-Cash Adjustments To Reconcile Net Income	61	116	37	47	55	60	43	23	25	19	38
Changes in Operating Assets and Liabilities, net	-42	28	-81	-42	-48	-68	-45	-14	5.00	-76	-158
Net Cash From Investing Activities	-16	-34	-18	-26	-22	-51	-18	-27	-51	-49	-25
Net Cash From Continuing Investing Activities	-16	-34	-18	-26	-22	-51	-18	-27	-51	-49	-25
Purchase of Property, Plant & Equipment	-18	-34	-18	-27	-22	-51	-18	-29	-51	-50	-25
Purchase of Investments	-	-	-	-	-	-	0.00	-	-	1.00	0.00
Sale of Property, Plant & Equipment	2.00	-	-	1.00	-	-	0.00	-	1.00	-	0.00
Net Cash From Financing Activities	-38	-143	-72	-87	-144	-246	-180	-129	-128	-125	-137
Net Cash From Continuing Financing Activities	-38	-143	-72	-87	-144	-246	-180	-129	-128	-125	-137
Repayment of Debt	-23	-347	-809	-1,470	-129	-234	-115	-114	-113	-112	-1,296
Repurchase of Common Equity	-	-	0.00	-	-	-	-45	-	-	-	0.00
Payment of Dividends	-15	-15	-15	-15	-14	-15	-15	-15	-14	-15	-17
Issuance of Debt	-	215	761	1,400	-	-	0.00	-	-	-	1,192
Other Financing Activities, net	-	4.00	-9.00	-2.00	-1.00	3.00	-5.00	-	-1.00	2.00	-16
Effect of Exchange Rate Changes	-4.00	-	-7.00	-4.00	14	-26	-2.00	10	5.00	-	3.00

This table presents MKS's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	1,273	2,212	2,414	2,614	3,416	3,904	4,540	11,495	9,118	8,590	8,796
Total Current Assets	940	999	1,236	1,464	1,434	1,804	2,147	2,794	2,696	2,474	2,510
Cash & Equivalents	228	229	334	644	415	608	966	909	875	714	675
Accounts Receivable	102	249	300	295	341	393	443	720	603	615	651
Inventories, net	153	276	339	385	462	501	577	977	991	893	921
Other Current Assets	18	51	54	66	106	74	85	187	227	252	263
Plant, Property, & Equipment, net	69	175	172	194	242	284	326	800	784	771	810
Total Noncurrent Assets	265	1,039	1,006	956	1,741	1,815	2,067	7,901	5,638	5,345	5,476
Goodwill	200	589	591	587	1,059	1,066	1,228	4,308	2,554	2,479	2,574
Intangible Assets	44	408	366	320	565	512	576	3,173	2,619	2,272	2,140
Other Noncurrent Operating Assets	21	32	38	39	112	230	263	420	465	594	762
Total Liabilities & Shareholders' Equity	1,273	2,212	2,414	2,614	3,416	3,904	4,540	11,495	9,118	8,590	8,796
Total Liabilities	112	970	825	741	1,393	1,543	1,653	7,012	6,646	6,268	6,077
Total Current Liabilities	91	237	290	263	318	374	460	952	848	775	927
Short-Term Debt	-	11	2.97	3.99	12	15	9.00	93	93	50	51
Accounts Payable	23	69	83	84	88	111	168	426	327	341	407
Other Current Liabilities	28	52	61	63	79	81	89	433	428	384	469
Total Noncurrent Liabilities	21	733	535	478	1,075	1,169	1,193	6,060	5,798	5,493	5,150
Long-Term Debt	-	601	390	344	872	815	808	4,834	4,696	4,488	4,150
Noncurrent Deferred & Payable Income Tax Liabilities	2.66	66	62	48	72	59	99	783	640	504	474
Noncurrent Employee Benefit Liabilities	13	45	52	56	44	50	49	138	151	141	149
Other Noncurrent Operating Liabilities	5.43	21	32	30	87	245	237	305	311	360	377
Commitments & Contingencies	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,161	1,242	1,589	1,873	2,023	2,361	2,887	4,483	2,472	2,322	2,719
Total Preferred & Common Equity	1,161	1,242	1,589	1,873	2,023	2,361	2,887	4,483	2,472	2,322	2,719
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,161	1,242	1,589	1,873	2,023	2,361	2,887	4,483	2,472	2,322	2,719
Common Stock	745	778	790	794	864	873	907	2,142	2,195	2,067	2,101
Retained Earnings	427	495	796	1,085	1,181	1,487	1,991	2,272	373	503	711
Accumulated Other Comprehensive Income / (Loss)	-11	-31	3.45	-5.66	-22	0.30	-11	69	-96	-248	-93

This table presents MKS's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	11,372	11,366	9,230	9,140	8,931	8,863	9,023	8,556	8,826	8,777	8,728
Total Current Assets	2,791	2,748	2,728	2,775	2,661	2,648	2,668	2,426	2,484	2,536	2,545
Cash & Equivalents	884	880	757	859	845	850	861	655	674	697	569
Accounts Receivable	730	572	631	618	576	597	609	639	649	611	775
Inventories, net	961	1,058	1,036	1,009	971	938	940	894	918	934	949
Other Current Assets	215	237	303	288	268	262	258	238	243	294	252
Plant, Property, & Equipment, net	655	794	777	761	766	759	770	774	801	769	795
Total Noncurrent Assets	7,926	7,824	5,725	5,604	5,504	5,456	5,585	5,356	5,541	5,472	5,388
Goodwill	3,851	4,327	2,575	2,540	2,511	2,495	2,567	2,496	2,570	2,563	2,565
Intangible Assets	3,653	3,108	2,728	2,614	2,501	2,418	2,443	2,238	2,267	2,196	2,065
Other Noncurrent Operating Assets	422	389	422	450	492	543	575	622	704	713	758
Total Liabilities & Shareholders' Equity	11,372	11,366	9,230	9,140	8,931	8,863	9,023	8,556	8,826	8,777	8,728
Total Liabilities	7,223	6,915	6,735	6,664	6,507	6,630	6,625	6,202	6,273	6,177	5,917
Total Current Liabilities	1,011	876	835	838	721	740	781	781	832	886	2,291
Short-Term Debt	95	88	88	87	50	50	50	50	51	51	1,398
Accounts Payable	410	372	314	309	290	291	306	323	355	382	448
Other Current Liabilities	219	416	433	442	381	399	425	408	426	453	445
Total Noncurrent Liabilities	6,212	6,039	5,900	5,826	5,786	5,890	5,844	5,421	5,441	5,291	3,626
Long-Term Debt	4,893	4,837	4,819	4,787	4,692	4,832	4,758	4,409	4,357	4,253	2,650
Noncurrent Deferred & Payable Income Tax Liabilities	893	751	628	595	622	588	590	502	504	483	450
Noncurrent Employee Benefit Liabilities	131	138	143	139	148	144	154	139	152	154	146
Other Noncurrent Operating Liabilities	295	313	310	305	324	326	342	371	428	401	380
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	4,149	4,451	2,495	2,476	2,424	2,233	2,398	2,354	2,553	2,600	2,811
Total Preferred & Common Equity	4,149	4,451	2,495	2,476	2,424	2,233	2,398	2,354	2,553	2,600	2,811
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,149	4,451	2,495	2,476	2,424	2,233	2,398	2,354	2,553	2,600	2,811
Common Stock	2,124	2,154	2,168	2,180	2,201	2,042	2,053	2,067	2,078	2,090	2,104
Retained Earnings	2,233	2,215	431	455	373	381	428	512	559	618	778
Accumulated Other Comprehensive Income / (Loss)	-208	82	-104	-159	-150	-190	-83	-225	-84	-108	-71

This table displays calculated financial ratios and metrics derived from MKS's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.18%	59.23%	47.91%	8.31%	-8.45%	22.64%	26.61%	20.24%	2.11%	-0.99%	9.62%
EBITDA Growth	13.23%	37.82%	130.95%	1.36%	-40.83%	62.08%	43.94%	16.83%	-223.76%	176.28%	0.46%
EBIT Growth	15.89%	-0.37%	204.81%	3.47%	-56.00%	108.31%	52.99%	-12.17%	-360.89%	131.63%	2.40%
NOPAT Growth	4.70%	7.24%	139.20%	31.01%	-57.00%	116.43%	54.18%	-18.07%	-329.25%	148.32%	-2.53%
Net Income Growth	5.63%	-14.30%	223.57%	15.85%	-64.27%	149.29%	57.43%	-39.56%	-652.85%	110.32%	55.26%
EPS Growth	5.56%	-14.91%	217.53%	15.91%	-64.29%	148.24%	56.40%	-43.84%	-595.32%	110.20%	55.52%
Operating Cash Flow Growth	35.70%	30.23%	97.24%	16.49%	-40.91%	109.82%	24.76%	-17.34%	-39.70%	65.52%	22.16%
Free Cash Flow Firm Growth	3,273.89%	-837.34%	138.13%	12.62%	-309.82%	156.95%	-34.56%	-2,123.41%	119.13%	-25.39%	-46.01%
Invested Capital Growth	2.67%	182.66%	0.50%	4.53%	59.28%	-1.24%	13.38%	219.31%	-24.87%	-3.76%	1.61%
Revenue Q/Q Growth	-3.63%	21.90%	5.90%	-2.41%	-18.63%	37.44%	3.65%	9.98%	-5.06%	1.19%	2.58%
EBITDA Q/Q Growth	-8.50%	48.19%	11.41%	-4.64%	-5.67%	16.27%	5.71%	6.04%	-14.87%	14.17%	0.46%
EBIT Q/Q Growth	-9.45%	33.41%	14.14%	-4.75%	-12.31%	22.89%	6.01%	-5.90%	-9.41%	32.28%	0.99%
NOPAT Q/Q Growth	-7.02%	31.70%	11.01%	-2.56%	-11.56%	22.61%	6.02%	-5.27%	-9.90%	-7.27%	4.00%
Net Income Q/Q Growth	-6.62%	23.53%	10.47%	-1.50%	-17.04%	26.22%	6.89%	-22.56%	-7.16%	512.90%	6.12%
EPS Q/Q Growth	-6.56%	23.57%	10.20%	-1.24%	-17.74%	26.35%	6.45%	-27.51%	-6.13%	510.87%	5.81%
Operating Cash Flow Q/Q Growth	6.56%	5.88%	8.58%	15.23%	-19.25%	15.75%	8.11%	-2.04%	-0.93%	-0.94%	-5.01%
Free Cash Flow Firm Q/Q Growth	3.23%	2.96%	0.20%	18.12%	-9.63%	16.70%	21.27%	-5.38%	32.89%	7.56%	-34.45%
Invested Capital Q/Q Growth	-2.17%	-0.29%	1.84%	-2.41%	0.13%	0.61%	0.03%	3.01%	-1.60%	-3.14%	0.61%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	44.61%	100.00%	46.53%	47.20%	43.71%	45.02%	46.78%	43.61%	45.33%	47.63%	46.73%
EBITDA Margin	21.97%	19.02%	29.69%	27.79%	17.96%	23.73%	26.98%	26.22%	-31.78%	24.48%	22.44%
Operating Margin	19.25%	12.14%	21.22%	23.81%	11.57%	19.49%	23.69%	17.40%	-42.90%	13.89%	13.43%
EBIT Margin	19.25%	12.05%	24.82%	23.71%	11.40%	19.36%	23.39%	17.08%	-43.65%	13.94%	13.02%
Profit (Net Income) Margin	15.03%	8.09%	17.70%	18.93%	7.39%	15.02%	18.68%	9.39%	-50.83%	5.30%	7.50%
Tax Burden Percent	76.69%	81.90%	75.76%	81.68%	78.97%	82.74%	82.86%	76.91%	95.49%	105.56%	97.04%
Interest Burden Percent	101.82%	82.02%	94.12%	97.74%	82.12%	93.79%	96.38%	71.45%	121.95%	36.00%	59.38%
Effective Tax Rate	23.31%	18.10%	24.24%	18.32%	21.03%	17.26%	17.14%	23.09%	0.00%	-5.56%	2.96%
Return on Invested Capital (ROIC)	24.21%	13.39%	21.63%	27.64%	8.97%	15.90%	23.12%	8.50%	-14.62%	8.39%	8.27%
ROIC Less NNEP Spread (ROIC-NNEP)	23.86%	23.40%	367.08%	31.59%	258.02%	0.86%	46.79%	1.04%	-33.61%	-0.29%	2.36%
Return on Net Nonoperating Assets (RNNOA)	-13.30%	-4.67%	2.33%	-4.94%	-1.76%	0.07%	-2.12%	0.53%	-38.33%	-0.46%	3.43%
Return on Equity (ROE)	10.91%	8.72%	23.96%	22.70%	7.21%	15.97%	21.00%	9.04%	-52.94%	7.93%	11.70%
Cash Return on Invested Capital (CROIC)	21.58%	-82.08%	21.13%	23.21%	-36.75%	17.14%	10.58%	-96.10%	13.79%	12.22%	6.67%
Operating Return on Assets (OROA)	12.54%	8.95%	20.56%	19.57%	7.18%	12.32%	16.34%	7.56%	-15.34%	5.65%	5.89%
Return on Assets (ROA)	9.79%	6.01%	14.66%	15.63%	4.66%	9.56%	13.05%	4.15%	-17.86%	2.15%	3.39%
Return on Common Equity (ROCE)	10.91%	8.72%	23.96%	22.70%	7.21%	15.97%	21.00%	9.04%	-52.94%	7.93%	11.70%
Return on Equity Simple (ROE_SIMPLE)	10.53%	8.44%	21.34%	20.97%	6.94%	14.82%	19.09%	7.43%	-74.47%	8.18%	0.00%
Net Operating Profit after Tax (NOPAT)	120	129	308	404	174	376	579	475	-1,088	526	512
NOPAT Margin	14.76%	9.94%	16.08%	19.45%	9.14%	16.12%	19.63%	13.38%	-30.03%	14.66%	13.03%
Net Nonoperating Expense Percent (NNEP)	0.35%	-10.01%	-345.45%	-3.95%	-249.05%	15.04%	-23.67%	7.46%	18.99%	8.68%	5.91%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	5.04%	-14.98%	7.66%	7.40%
Cost of Revenue to Revenue	55.40%	0.00%	53.47%	52.80%	56.29%	54.98%	53.22%	56.39%	54.67%	52.37%	53.27%
SG&A Expenses to Revenue	15.87%	17.60%	15.14%	14.37%	17.39%	15.15%	13.05%	13.76%	18.64%	18.80%	18.42%
R&D to Revenue	8.40%	8.54%	6.92%	6.54%	8.64%	7.42%	6.78%	6.79%	7.95%	7.56%	7.61%
Operating Expenses to Revenue	25.35%	87.86%	25.30%	23.39%	32.14%	25.54%	23.08%	26.22%	88.24%	33.74%	33.30%
Earnings before Interest and Taxes (EBIT)	157	156	476	492	217	451	690	606	-1,581	500	512
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	179	246	569	577	341	553	796	930	-1,151	878	882
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.53	2.41	3.07	1.78	2.87	3.42	3.28	1.23	2.76	3.02	3.94
Price to Tangible Book Value (P/TBV)	1.94	12.23	7.72	3.46	14.49	10.33	8.73	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.18	2.31	2.54	1.61	3.05	3.47	3.21	1.56	1.88	1.95	2.73
Price to Earnings (P/E)	14.53	28.61	14.37	8.50	41.31	23.08	17.16	16.60	0.00	36.90	36.35
Dividend Yield	2.02%	1.22%	0.79%	1.26%	0.75%	0.55%	0.50%	1.06%	0.86%	0.84%	0.55%
Earnings Yield	6.88%	3.50%	6.96%	11.76%	2.42%	4.33%	5.83%	6.02%	0.00%	2.71%	2.75%
Enterprise Value to Invested Capital (EV/IC)	2.23	2.24	3.30	1.98	2.59	3.43	3.47	1.12	1.68	1.76	2.28
Enterprise Value to Revenue (EV/Rev)	1.38	2.45	2.46	1.43	3.24	3.46	3.13	2.69	2.96	3.02	3.62
Enterprise Value to EBITDA (EV/EBITDA)	6.26	12.90	8.29	5.14	18.04	14.58	11.60	10.26	0.00	12.34	16.16
Enterprise Value to EBIT (EV/EBIT)	7.14	20.36	9.91	6.02	28.42	17.88	13.38	15.75	0.00	21.67	27.83
Enterprise Value to NOPAT (EV/NOPAT)	9.31	24.67	15.30	7.34	35.45	21.47	15.94	20.11	0.00	20.61	27.81
Enterprise Value to Operating Cash Flow (EV/OCF)	8.09	17.64	13.27	7.16	25.17	15.72	14.42	18.04	33.64	20.52	22.09
Enterprise Value to Free Cash Flow (EV/FCFF)	10.45	0.00	15.66	8.74	0.00	19.91	34.82	0.00	10.46	14.15	34.47
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.49	0.25	0.19	0.44	0.35	0.28	1.10	1.94	1.95	1.55
Long-Term Debt to Equity	0.00	0.48	0.25	0.18	0.43	0.35	0.28	1.08	1.90	1.93	1.53
Financial Leverage	-0.56	-0.20	0.01	-0.16	-0.01	0.08	-0.05	0.51	1.14	1.61	1.46
Leverage Ratio	1.11	1.45	1.63	1.45	1.55	1.67	1.61	2.18	2.96	3.69	3.45
Compound Leverage Factor	1.13	1.19	1.54	1.42	1.27	1.57	1.55	1.55	3.61	1.33	2.05
Debt to Total Capital	0.00%	33.02%	19.83%	15.66%	30.40%	26.00%	22.06%	52.36%	65.96%	66.15%	60.71%
Short-Term Debt to Total Capital	0.00%	0.59%	0.15%	0.18%	0.42%	0.45%	0.24%	0.99%	1.28%	0.73%	0.74%
Long-Term Debt to Total Capital	0.00%	32.43%	19.68%	15.48%	29.99%	25.55%	21.81%	51.37%	64.67%	65.42%	59.97%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	66.98%	80.17%	84.34%	69.60%	74.00%	77.94%	47.64%	34.04%	33.85%	39.29%
Debt to EBITDA	0.00	2.49	0.69	0.60	2.59	1.50	1.03	5.30	-4.16	5.17	4.76
Net Debt to EBITDA	0.00	0.73	-0.28	-0.66	1.04	-0.02	-0.28	4.32	-3.40	4.36	4.00
Long-Term Debt to EBITDA	0.00	2.44	0.69	0.60	2.55	1.47	1.02	5.20	-4.08	5.11	4.71
Debt to NOPAT	0.00	4.75	1.28	0.86	5.09	2.21	1.41	10.38	-4.40	8.63	8.20
Net Debt to NOPAT	0.00	1.39	-0.52	-0.94	2.04	-0.03	-0.39	8.47	-3.60	7.27	6.88
Long-Term Debt to NOPAT	0.00	4.67	1.27	0.85	5.02	2.17	1.40	10.19	-4.32	8.54	8.10
Altman Z-Score	11.79	3.40	5.92	5.25	4.14	5.09	5.64	1.42	0.74	1.60	2.03
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	10.33	4.21	4.27	5.56	4.51	4.83	4.67	2.93	3.18	3.19	2.71
Quick Ratio	8.35	2.81	2.91	3.85	2.72	3.29	3.23	1.71	1.74	1.71	1.43
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	107	-789	301	339	-711	405	265	-5,363	1,026	766	413
Operating Cash Flow to CapEx	1,114.02%	941.79%	1,135.37%	657.87%	1,121.56%	603.53%	735.63%	341.29%	379.76%	451.28%	444.83%
Free Cash Flow to Firm to Interest Expense	748.62	-25.79	9.71	20.06	-16.13	13.97	10.60	-30.30	2.82	2.25	1.86
Operating Cash Flow to Interest Expense	967.10	5.88	11.46	24.49	5.54	17.69	25.60	2.99	0.88	1.55	2.91
Operating Cash Flow Less CapEx to Interest Expense	880.29	5.26	10.45	20.76	5.05	14.76	22.12	2.11	0.65	1.21	2.25
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.65	0.74	0.83	0.83	0.63	0.64	0.70	0.44	0.35	0.41	0.45
Accounts Receivable Turnover	7.81	7.39	6.98	6.97	5.97	6.35	7.06	6.10	5.48	5.89	6.21
Inventory Turnover	2.93	0.00	3.33	3.03	2.53	2.66	2.91	2.57	2.01	1.99	2.31
Fixed Asset Turnover	11.49	10.64	11.06	11.33	8.71	8.86	9.67	6.30	4.57	4.61	4.97
Accounts Payable Turnover	15.72	0.00	13.49	13.17	12.42	12.87	11.27	6.73	5.26	5.62	5.60
Days Sales Outstanding (DSO)	46.72	49.40	52.30	52.40	61.15	57.48	51.70	59.84	66.66	61.99	58.78
Days Inventory Outstanding (DIO)	124.65	0.00	109.54	120.56	144.51	137.27	125.36	141.80	181.39	183.08	158.10
Days Payable Outstanding (DPO)	23.22	0.00	27.05	27.71	29.39	28.35	32.39	54.20	69.41	64.91	65.19
Cash Conversion Cycle (CCC)	148.14	49.40	134.79	145.25	176.27	166.39	144.67	147.44	178.65	180.16	151.68
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	503	1,421	1,428	1,493	2,377	2,348	2,662	8,500	6,386	6,146	6,245
Invested Capital Turnover	1.64	1.35	1.35	1.42	0.98	0.99	1.18	0.64	0.49	0.57	0.63
Increase / (Decrease) in Invested Capital	13	918	7.11	65	885	-29	314	5,838	-2,114	-240	99
Enterprise Value (EV)	1,119	3,177	4,713	2,961	6,154	8,065	9,231	9,545	10,730	10,834	14,249
Market Capitalization	1,777	2,998	4,874	3,342	5,800	8,078	9,456	5,528	6,816	7,010	10,723
Book Value per Share	$21.80	$23.17	$29.26	$34.70	$37.12	$42.82	$52.06	$67.41	$36.96	$34.50	$40.48
Tangible Book Value per Share	$17.22	$4.58	$11.63	$17.90	$7.34	$14.19	$19.53	($45.08)	($40.39)	($36.09)	($29.70)
Total Capital	1,161	1,854	1,982	2,221	2,907	3,190	3,704	9,410	7,261	6,860	6,920
Total Debt	0.00	612	393	348	884	830	817	4,927	4,789	4,538	4,201
Total Long-Term Debt	0.00	601	390	344	872	815	808	4,834	4,696	4,488	4,150
Net Debt	-658	179	-161	-381	354	-13	-225	4,017	3,914	3,824	3,526
Capital Expenditures (CapEx)	12	19	31	63	22	85	87	155	84	117	145
Debt-free, Cash-free Net Working Capital (DFCFNWC)	190	349	406	487	604	609	654	1,025	1,066	1,035	959
Debt-free Net Working Capital (DFNWC)	849	772	949	1,205	1,128	1,445	1,696	1,935	1,941	1,749	1,634
Net Working Capital (NWC)	849	761	946	1,201	1,116	1,431	1,687	1,842	1,848	1,699	1,583
Net Nonoperating Expense (NNE)	-2.19	24	-31	11	33	26	28	142	753	336	217
Net Nonoperating Obligations (NNO)	-658	179	-161	-381	354	-13	-225	4,017	3,914	3,824	3,526
Total Depreciation and Amortization (D&A)	22	90	93	85	125	102	106	324	430	378	370
Debt-free, Cash-free Net Working Capital to Revenue	23.39%	26.95%	21.19%	23.45%	31.79%	26.14%	22.17%	28.90%	29.43%	28.86%	24.40%
Debt-free Net Working Capital to Revenue	104.30%	59.63%	49.55%	58.06%	59.37%	62.02%	57.49%	54.55%	53.59%	48.77%	41.57%
Net Working Capital to Revenue	104.30%	58.79%	49.40%	57.87%	58.73%	61.39%	57.19%	51.93%	51.02%	47.38%	40.27%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.30	$1.96	$6.26	$7.22	$2.57	$6.36	$9.95	$5.57	($27.54)	$2.82	$4.39
Adjusted Weighted Average Basic Shares Outstanding	53.28M	53.47M	54.14M	54.41M	54.71M	55.10M	55.40M	59.70M	66.80M	67.30M	67.30M
Adjusted Diluted Earnings per Share	$2.28	$1.94	$6.16	$7.14	$2.55	$6.33	$9.90	$5.56	($27.54)	$2.81	$4.37
Adjusted Weighted Average Diluted Shares Outstanding	53.56M	54.05M	55.07M	54.99M	55.11M	55.30M	55.70M	59.90M	66.80M	67.60M	67.70M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	53.24M	53.82M	54.49M	54.20M	54.87M	55.22M	55.52M	66.67M	67.06M	67.38M	67.25M
Normalized Net Operating Profit after Tax (NOPAT)	122	156	320	410	207	387	613	517	267	359	548
Normalized NOPAT Margin	14.96%	12.02%	16.71%	19.75%	10.89%	16.62%	20.78%	14.57%	7.38%	10.01%	13.95%
Pre Tax Income Margin	19.60%	9.88%	23.36%	23.18%	9.36%	18.15%	22.54%	12.21%	-53.23%	5.02%	7.73%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1,095.19	5.10	15.35	29.12	4.91	15.55	27.60	3.42	-4.34	1.47	2.31
NOPAT to Interest Expense	839.91	4.21	9.94	23.88	3.94	12.95	23.17	2.68	-2.99	1.54	2.31
EBIT Less CapEx to Interest Expense	1,008.38	4.47	14.34	25.40	4.42	12.62	24.12	2.55	-4.57	1.12	1.65
NOPAT Less CapEx to Interest Expense	753.10	3.58	8.93	20.16	3.44	10.02	19.69	1.81	-3.22	1.20	1.65
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	29.41%	34.69%	11.26%	10.79%	30.98%	12.57%	8.53%	15.62%	-3.20%	31.05%	20.00%
Augmented Payout Ratio	40.28%	36.17%	11.26%	29.88%	30.98%	12.57%	8.53%	15.62%	-3.20%	31.05%	35.25%

This table displays calculated financial ratios and metrics derived from MKS's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	67,248,357.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	67,248,357.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	1.25
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-2.31%	-17.77%	9.32%	-11.57%	-3.86%	4.70%	7.83%	9.70%	10.27%	10.59%	15.17%
EBITDA Growth	-20.90%	-55.81%	73.73%	114.32%	2.36%	92.37%	-0.98%	-4.37%	5.53%	1.76%	17.73%
EBIT Growth	-6.72%	-91.89%	3,533.33%	107.85%	10.81%	1,016.67%	2.75%	-6.72%	10.57%	3.73%	33.93%
NOPAT Growth	1,081.82%	-87.93%	11,854.89%	111.18%	-36.77%	869.42%	16.90%	-12.44%	-8.09%	10.92%	25.43%
Net Income Growth	550.00%	-227.78%	135.71%	101.30%	58.97%	230.43%	246.67%	169.57%	19.35%	18.89%	61.54%
EPS Growth	544.44%	-274.14%	134.38%	101.25%	58.62%	232.67%	250.00%	178.79%	19.57%	17.91%	53.25%
Operating Cash Flow Growth	-19.60%	-1.63%	81.08%	306.78%	1.88%	-2.76%	110.45%	35.25%	20.86%	-19.32%	-62.41%
Free Cash Flow Firm Growth	135.37%	137.34%	139.61%	110.35%	-85.93%	-81.41%	-88.50%	-81.81%	-6.38%	-81.29%	-103.58%
Invested Capital Growth	-21.35%	-24.87%	-25.60%	-5.72%	-2.23%	-3.76%	-2.56%	0.37%	-2.17%	1.61%	2.14%
Revenue Q/Q Growth	-7.08%	-4.18%	-2.80%	2.19%	1.01%	4.35%	0.11%	3.95%	1.54%	4.66%	4.26%
EBITDA Q/Q Growth	113.26%	-44.34%	73.73%	11.71%	-5.24%	4.61%	-10.57%	7.88%	4.57%	0.87%	3.46%
EBIT Q/Q Growth	106.50%	-89.19%	808.33%	22.94%	-8.21%	8.94%	-16.42%	11.61%	8.80%	2.21%	7.91%
NOPAT Q/Q Growth	117.62%	-92.30%	419.78%	58.66%	-0.38%	18.00%	-37.32%	18.83%	4.58%	42.40%	-29.12%
Net Income Q/Q Growth	102.20%	-276.92%	121.74%	53.33%	169.57%	45.16%	-42.22%	19.23%	19.35%	44.59%	-21.50%
EPS Q/Q Growth	102.19%	-274.14%	121.78%	50.00%	178.79%	45.65%	-42.54%	19.48%	19.57%	43.64%	-25.32%
Operating Cash Flow Q/Q Growth	371.19%	13.13%	-62.98%	82.09%	33.61%	7.98%	-19.89%	17.02%	19.39%	-27.92%	-62.68%
Free Cash Flow Firm Q/Q Growth	139.79%	8.06%	6.04%	-77.30%	-45.93%	42.85%	-34.40%	-64.11%	178.36%	-71.44%	-112.54%
Invested Capital Q/Q Growth	-2.32%	-1.60%	-1.03%	-0.89%	1.29%	-3.14%	0.20%	2.09%	-1.27%	0.61%	0.72%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	45.71%	46.02%	47.81%	47.24%	48.21%	47.27%	47.44%	46.56%	46.66%	46.33%	47.03%
EBITDA Margin	22.75%	13.21%	23.62%	25.82%	24.22%	24.28%	21.69%	22.51%	23.18%	22.34%	22.17%
Operating Margin	12.66%	2.58%	12.21%	14.32%	14.29%	14.65%	11.86%	13.87%	13.97%	13.93%	13.82%
EBIT Margin	11.91%	1.34%	12.56%	15.11%	13.73%	14.33%	11.97%	12.85%	13.77%	13.44%	13.91%
Profit (Net Income) Margin	4.18%	-7.73%	1.73%	2.59%	6.92%	9.63%	5.56%	6.37%	7.49%	10.35%	7.79%
Tax Burden Percent	177.27%	86.25%	78.95%	104.55%	103.33%	113.92%	88.14%	86.11%	88.10%	120.22%	82.35%
Interest Burden Percent	19.82%	-666.67%	17.43%	16.42%	48.78%	58.96%	52.68%	57.60%	61.76%	64.03%	68.00%
Effective Tax Rate	-77.27%	0.00%	21.05%	-4.55%	-3.33%	-13.92%	11.86%	13.89%	11.90%	-20.22%	17.65%
Return on Invested Capital (ROIC)	11.62%	0.88%	4.81%	8.30%	8.15%	9.55%	6.12%	7.12%	7.51%	10.62%	7.45%
ROIC Less NNEP Spread (ROIC-NNEP)	7.42%	-1.27%	3.08%	5.62%	6.39%	7.85%	4.93%	5.72%	6.25%	8.82%	6.39%
Return on Net Nonoperating Assets (RNNOA)	9.10%	-1.45%	3.56%	9.72%	10.43%	12.66%	7.95%	9.29%	9.45%	12.87%	9.00%
Return on Equity (ROE)	20.71%	-0.57%	8.37%	18.02%	18.58%	22.22%	14.07%	16.41%	16.96%	23.49%	16.45%
Cash Return on Invested Capital (CROIC)	10.48%	13.79%	15.67%	9.94%	11.09%	12.22%	10.92%	7.66%	10.05%	6.67%	6.45%
Operating Return on Assets (OROA)	4.43%	0.47%	4.57%	5.98%	5.36%	5.80%	5.00%	5.43%	5.93%	6.08%	6.56%
Return on Assets (ROA)	1.56%	-2.72%	0.63%	1.03%	2.70%	3.90%	2.32%	2.69%	3.22%	4.68%	3.67%
Return on Common Equity (ROCE)	20.71%	-0.57%	8.37%	18.02%	18.58%	22.22%	14.07%	16.41%	16.96%	23.49%	16.45%
Return on Equity Simple (ROE_SIMPLE)	-69.39%	0.00%	-73.60%	0.36%	1.29%	0.00%	9.64%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	209	16	84	133	132	156	98	116	122	173	123
NOPAT Margin	22.44%	1.80%	9.64%	14.97%	14.76%	16.69%	10.45%	11.95%	12.30%	16.74%	11.38%
Net Nonoperating Expense Percent (NNEP)	4.19%	2.15%	1.73%	2.68%	1.77%	1.71%	1.19%	1.40%	1.26%	1.80%	1.06%
Return On Investment Capital (ROIC_SIMPLE)	-	0.22%	-	-	-	2.28%	1.44%	1.67%	1.76%	2.50%	1.79%
Cost of Revenue to Revenue	54.29%	53.98%	52.19%	52.76%	51.79%	52.73%	52.56%	53.44%	53.34%	53.68%	52.97%
SG&A Expenses to Revenue	17.92%	18.14%	19.59%	18.15%	18.64%	18.82%	19.77%	17.99%	18.22%	17.80%	17.63%
R&D to Revenue	7.62%	7.84%	8.06%	7.44%	7.81%	6.95%	7.48%	7.81%	7.69%	7.45%	7.51%
Operating Expenses to Revenue	33.05%	43.45%	35.60%	32.92%	33.93%	32.62%	35.58%	32.68%	32.69%	32.40%	33.21%
Earnings before Interest and Taxes (EBIT)	111	12	109	134	123	134	112	125	136	139	150
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	212	118	205	229	217	227	203	219	229	231	239
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.32	2.76	3.66	3.93	3.05	3.02	2.29	2.61	3.20	3.94	5.50
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.50	1.88	2.40	2.45	2.06	1.95	1.48	1.78	2.17	2.73	3.79
Price to Earnings (P/E)	0.00	0.00	0.00	1,096.82	235.96	36.90	23.79	25.05	29.90	36.35	47.26
Dividend Yield	1.03%	0.86%	0.66%	0.67%	0.81%	0.84%	1.10%	0.89%	0.71%	0.55%	0.40%
Earnings Yield	0.00%	0.00%	0.00%	0.09%	0.42%	2.71%	4.20%	3.99%	3.34%	2.75%	2.12%
Enterprise Value to Invested Capital (EV/IC)	1.50	1.68	2.02	2.04	1.77	1.76	1.49	1.65	1.92	2.28	3.01
Enterprise Value to Revenue (EV/Rev)	2.56	2.96	3.46	3.58	3.18	3.02	2.52	2.78	3.11	3.62	4.65
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	16.76	14.64	12.34	10.51	12.01	13.58	16.16	20.62
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	34.99	29.79	21.67	18.30	21.05	23.51	27.83	34.42
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	48.91	19.87	20.61	17.73	20.65	24.19	27.81	35.50
Enterprise Value to Operating Cash Flow (EV/OCF)	30.29	33.64	36.61	24.16	21.13	20.52	15.29	16.12	17.55	22.09	33.99
Enterprise Value to Free Cash Flow (EV/FCFF)	12.63	10.46	11.01	19.95	15.82	14.15	13.52	21.64	18.90	34.47	47.17
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.97	1.94	1.96	2.19	2.01	1.95	1.89	1.73	1.66	1.55	1.44
Long-Term Debt to Equity	1.93	1.90	1.94	2.16	1.98	1.93	1.87	1.71	1.64	1.53	0.94
Financial Leverage	1.23	1.14	1.15	1.73	1.63	1.61	1.61	1.62	1.51	1.46	1.41
Leverage Ratio	3.10	2.96	2.95	3.83	3.73	3.69	3.66	3.70	3.56	3.45	3.35
Compound Leverage Factor	0.61	-19.76	0.51	0.63	1.82	2.18	1.93	2.13	2.20	2.21	2.28
Debt to Total Capital	66.31%	65.96%	66.17%	68.62%	66.72%	66.15%	65.45%	63.32%	62.34%	60.71%	59.02%
Short-Term Debt to Total Capital	1.18%	1.28%	0.70%	0.70%	0.69%	0.73%	0.73%	0.73%	0.74%	0.74%	20.38%
Long-Term Debt to Total Capital	65.13%	64.67%	65.48%	67.91%	66.03%	65.42%	64.71%	62.59%	61.60%	59.97%	38.64%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	33.69%	34.04%	33.83%	31.38%	33.28%	33.85%	34.55%	36.68%	37.66%	39.29%	40.98%
Debt to EBITDA	-4.86	-4.16	-4.46	6.39	6.25	5.17	5.09	5.09	4.90	4.76	4.41
Net Debt to EBITDA	-4.01	-3.40	-3.66	5.28	5.13	4.36	4.34	4.31	4.11	4.00	3.79
Long-Term Debt to EBITDA	-4.78	-4.08	-4.41	6.32	6.19	5.11	5.03	5.03	4.84	4.71	2.89
Debt to NOPAT	-4.92	-4.40	-4.68	18.65	8.48	8.63	8.59	8.76	8.74	8.20	7.59
Net Debt to NOPAT	-4.06	-3.60	-3.84	15.40	6.96	7.27	7.33	7.42	7.32	6.88	6.52
Long-Term Debt to NOPAT	-4.84	-4.32	-4.63	18.46	8.39	8.54	8.50	8.65	8.63	8.10	4.97
Altman Z-Score	1.30	1.32	1.59	1.57	1.42	1.46	1.31	1.42	1.62	1.89	2.25
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.31	3.18	3.69	3.58	3.42	3.19	3.11	2.99	2.86	2.71	1.11
Quick Ratio	1.76	1.74	1.97	1.96	1.88	1.71	1.66	1.59	1.48	1.43	0.59
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,971	2,130	2,259	513	277	396	260	93	260	74	-9.29
Operating Cash Flow to CapEx	1,000.00%	532.35%	372.22%	469.23%	740.91%	345.10%	783.33%	568.97%	394.00%	284.00%	212.00%
Free Cash Flow to Firm to Interest Expense	21.20	21.74	23.53	4.38	4.02	6.71	4.64	1.64	4.72	1.37	-0.19
Operating Cash Flow to Interest Expense	1.72	1.85	0.70	1.04	2.36	2.98	2.52	2.89	3.58	2.63	1.06
Operating Cash Flow Less CapEx to Interest Expense	1.55	1.50	0.51	0.82	2.04	2.12	2.20	2.39	2.67	1.70	0.56
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.37	0.35	0.36	0.40	0.39	0.41	0.42	0.42	0.43	0.45	0.47
Accounts Receivable Turnover	5.66	5.48	6.44	5.83	5.78	5.89	6.01	6.00	6.28	6.21	5.76
Inventory Turnover	2.13	2.01	1.95	1.93	1.92	1.99	2.06	2.12	2.17	2.31	2.36
Fixed Asset Turnover	5.39	4.57	4.74	4.66	4.63	4.61	4.75	4.79	4.98	4.97	5.19
Accounts Payable Turnover	5.84	5.26	5.96	6.31	6.07	5.62	6.25	6.10	5.91	5.60	5.64
Days Sales Outstanding (DSO)	64.48	66.66	56.69	62.60	63.19	61.99	60.68	60.80	58.10	58.78	63.36
Days Inventory Outstanding (DIO)	171.28	181.39	187.58	188.71	190.52	183.08	177.55	172.03	168.31	158.10	154.78
Days Payable Outstanding (DPO)	62.51	69.41	61.20	57.84	60.12	64.91	58.36	59.88	61.79	65.19	64.75
Cash Conversion Cycle (CCC)	173.25	178.65	183.07	193.48	193.58	180.16	179.87	172.95	164.62	151.68	153.39
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	6,490	6,386	6,320	6,264	6,345	6,146	6,158	6,287	6,207	6,245	6,290
Invested Capital Turnover	0.52	0.49	0.50	0.55	0.55	0.57	0.59	0.60	0.61	0.63	0.65
Increase / (Decrease) in Invested Capital	-1,762	-2,114	-2,175	-380	-145	-240	-162	23	-138	99	132
Enterprise Value (EV)	9,753	10,730	12,776	12,806	11,262	10,834	9,204	10,398	11,919	14,249	18,933
Market Capitalization	5,739	6,816	8,880	8,775	7,315	7,010	5,400	6,664	8,312	10,723	15,454
Book Value per Share	$37.03	$36.96	$36.18	$33.23	$35.64	$34.50	$34.94	$38.06	$38.71	$40.48	$41.80
Tangible Book Value per Share	($40.05)	($40.39)	($38.63)	($39.88)	($38.82)	($36.09)	($35.32)	($34.05)	($32.15)	($29.70)	($27.05)
Total Capital	7,350	7,261	7,166	7,115	7,206	6,860	6,813	6,961	6,904	6,920	6,859
Total Debt	4,874	4,789	4,742	4,882	4,808	4,538	4,459	4,408	4,304	4,201	4,048
Total Long-Term Debt	4,787	4,696	4,692	4,832	4,758	4,488	4,409	4,357	4,253	4,150	2,650
Net Debt	4,014	3,914	3,896	4,031	3,947	3,824	3,804	3,734	3,607	3,526	3,479
Capital Expenditures (CapEx)	16	34	18	26	22	51	18	29	50	50	25
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,164	1,066	1,144	1,107	1,076	1,035	1,040	1,029	1,004	959	1,083
Debt-free Net Working Capital (DFNWC)	2,024	1,941	1,990	1,958	1,937	1,749	1,695	1,703	1,701	1,634	1,652
Net Working Capital (NWC)	1,937	1,848	1,940	1,908	1,887	1,699	1,645	1,652	1,650	1,583	254
Net Nonoperating Expense (NNE)	170	85	69	110	70	66	46	54	48	66	39
Net Nonoperating Obligations (NNO)	4,014	3,914	3,896	4,031	3,947	3,824	3,804	3,734	3,607	3,526	3,479
Total Depreciation and Amortization (D&A)	101	106	96	95	94	93	91	94	93	92	89
Debt-free, Cash-free Net Working Capital to Revenue	30.51%	29.43%	30.95%	30.92%	30.36%	28.86%	28.46%	27.51%	26.20%	24.40%	26.59%
Debt-free Net Working Capital to Revenue	53.05%	53.59%	53.84%	54.69%	54.66%	48.77%	46.39%	45.53%	44.39%	41.57%	40.56%
Net Working Capital to Revenue	50.77%	51.02%	52.49%	53.30%	53.24%	47.38%	45.02%	44.17%	43.06%	40.27%	6.24%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.59	($1.02)	$0.22	$0.34	$0.92	$1.34	$0.77	$0.92	$1.10	$1.60	$1.24
Adjusted Weighted Average Basic Shares Outstanding	66.90M	66.80M	67M	67.30M	67.40M	67.30M	67.40M	67.20M	67.30M	67.30M	67.40M
Adjusted Diluted Earnings per Share	$0.58	($1.01)	$0.22	$0.33	$0.92	$1.34	$0.77	$0.92	$1.10	$1.58	$1.18
Adjusted Weighted Average Diluted Shares Outstanding	67.10M	66.80M	67.40M	67.50M	67.60M	67.60M	67.70M	67.40M	67.60M	67.70M	71.10M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	66.88M	67.06M	67.20M	67.29M	67.30M	67.38M	67.07M	67.16M	67.17M	67.25M	67.54M
Normalized Net Operating Profit after Tax (NOPAT)	84	75	87	92	92	98	112	121	125	109	128
Normalized NOPAT Margin	9.01%	8.39%	10.00%	10.34%	10.31%	10.48%	11.96%	12.39%	12.66%	10.56%	11.84%
Pre Tax Income Margin	2.36%	-8.96%	2.19%	2.48%	6.70%	8.45%	6.30%	7.40%	8.50%	8.61%	9.46%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.19	0.12	1.14	1.15	1.78	2.27	2.00	2.19	2.47	2.57	3.00
NOPAT to Interest Expense	2.25	0.16	0.87	1.13	1.92	2.65	1.75	2.04	2.21	3.21	2.45
EBIT Less CapEx to Interest Expense	1.02	-0.22	0.95	0.92	1.46	1.41	1.68	1.68	1.56	1.65	2.50
NOPAT Less CapEx to Interest Expense	2.08	-0.18	0.68	0.91	1.60	1.78	1.43	1.53	1.30	2.28	1.95
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-3.43%	-3.20%	-3.31%	750.00%	190.32%	31.05%	25.99%	22.18%	21.22%	20.00%	18.65%
Augmented Payout Ratio	-3.43%	-3.20%	-3.31%	750.00%	190.32%	31.05%	25.99%	22.18%	21.22%	35.25%	18.65%

Financials Breakdown Chart

Key Financial Trends

Here is a concise year-over-year read on MKSI (MKS Instruments) using the latest four quarterly data sets provided. The focus is on trends in revenue, profitability, cash flow, and balance-sheet health to help retail investors assess the stock’s performance over the last year and into 2026.

Revenue growth: Q4 2025 operating revenue rose to $1,034,000,000, up from $935,000,000 in Q4 2024, signaling a healthy top-line expansion.
Earnings per share improvement: Diluted EPS increased to $1.58 in Q4 2025 from $1.34 in Q4 2024, reflecting stronger profitability on a per-share basis.
Net income growth: Net income attributable to common shareholders was $107,000,000 in Q4 2025, up from $90,000,000 in Q4 2024, highlighting improved quarterly earnings.
Solid operating cash flow and free cash flow: Net cash from continuing operating activities was $142,000,000 in Q4 2025, with estimated free cash flow around $92,000,000 after capex (~$50,000,000), signaling robust cash generation.
Shareholder returns: The company continues to pay a quarterly cash dividend of $0.22 per share, supporting a cash-return theme for shareholders.
Profitability margin context: Gross margin remained in the mid-40s (Total Gross Profit of $479,000,000 on $1,034,000,000 revenue ≈ 46.3%), a stable but slightly lower margin versus Q4 2024’s ≈47.3% (442,000,000 on 935,000,000).
Liquidity position: Cash and equivalents on the balance sheet were around $697,000,000 in earlier 2025 quarters (Q3 level shown), with total current liabilities about $886,000,000, indicating solid liquidity but with modest leverage against short-term obligations.
Leverage and debt: Long-term debt sits around $4.25–4.34 billion across recent quarters, with minimal near-term debt pressure (short-term debt around $51 million in Q3 2025). Debt levels appear manageable within current cash generation.
Capital expenditure: Purchase of property, plant & equipment in recent quarters runs around $50–55 million per quarter, indicating ongoing capacity investment to support growth.
Share count and profitability baseline: Weighted-average shares outstanding are in the 67–68 million range (basic/diluted), with EPS reflecting the solid profitability trend observed in 2025.
Financing activity drag in Q4 2025: Net cash from financing activities was -$125,000,000, reflecting cash outflows (e.g., debt repayments/dividends), which weighed on the quarterly cash flow mix.
Quarterly cash change: Net change in cash and equivalents for Q4 2025 was -$22,000,000, indicating a modest burn on cash even as operating cash flow remained positive.
Working-capital headwinds in the quarter: Changes in operating assets and liabilities, net, were -$76,000,000 in Q4 2025, signaling a cash-usage tilt within the operating cycle that partially offset strong operating cash flow.

05/19/26 07:41 PM ETAI Generated. May Contain Errors.

MKS Financials - Frequently Asked Questions

According to the most recent income statement we have on file, MKS's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

MKS's net income appears to be on a downward trend, with a most recent value of $295 million in 2025, rising from $122.30 million in 2015. The previous period was $190 million in 2024. Check out MKS's forecast to explore projected trends and price targets.

MKS's total operating income in 2025 was $528 million, based on the following breakdown:

Total Gross Profit: $1.84 billion
Total Operating Expenses: $1.31 billion

Over the last 10 years, MKS's total revenue changed from $813.52 million in 2015 to $3.93 billion in 2025, a change of 383.2%.

MKS's total liabilities were at $6.08 billion at the end of 2025, a 3.0% decrease from 2024, and a 5,303.4% increase since 2015.

In the past 10 years, MKS's cash and equivalents has ranged from $227.57 million in 2015 to $966 million in 2021, and is currently $675 million as of their latest financial filing in 2025.

Over the last 10 years, MKS's book value per share changed from 21.80 in 2015 to 40.48 in 2025, a change of 85.7%.

Related Companies

Financial statements for NASDAQ:MKSI last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MKS (MKSI) Financials

Financials Breakdown Chart

Key Financial Trends

MKS Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

MKS (MKSI) Financials

Annual Income Statements for MKS

Quarterly Income Statements for MKS

Annual Cash Flow Statements for MKS

Quarterly Cash Flow Statements for MKS

Annual Balance Sheets for MKS

Quarterly Balance Sheets for MKS

Annual Metrics And Ratios for MKS

Quarterly Metrics And Ratios for MKS

Financials Breakdown Chart

Key Financial Trends

MKS Financials - Frequently Asked Questions

When does MKS's financial year end?

How has MKS's net income changed over the last 10 years?

What is MKS's operating income?

How has MKS's revenue changed over the last 10 years?

How much debt does MKS have?

How much cash does MKS have?

How has MKS's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools